LAVA Therapeutics NV LVTX Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	0	149.89M	143.43M	135.28M	122.54M	111.02M	101.71M	99.08M
Total Current Assets	0	147.6M	140.53M	130.61M	118.52M	107.92M	98.9M	96.67M
Cash and Equivalents	0	64.33M	100.33M	100.6M	87.61M	62.66M	44.23M	43.19M
Total Non-Current Assets	0	1.96M	3.67M	2.82M	2.25M	2.04M	3.52M	1.62M
Total Liabilities	0	57.23M	57.39M	60.01M	58.65M	56.42M	50.53M	48.41M
Total Current Liabilities	0	17.86M	21.95M	23.58M	22.33M	20.75M	14.94M	13.03M
Total Non-Current Liabilities	0	43.74M	35.86M	37.86M	37.63M	36.34M	36.18M	35.77M
Common Equity	0	3.72M	3.72M	3.72M	3.72M	3.72M	3.72M	3.72M
Retained Earnings	0	-93.46M	-108.07M	-122.01M	-134.71M	-141.91M	-148.07M	-148.48M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	8.8M	20.49M	139.25M	143.43M	101.71M
Total Current Assets	7.62M	18.22M	136.51M	140.53M	98.9M
Cash and Equivalents	7.34M	15.82M	90.87M	100.33M	44.23M
Total Non-Current Assets	5.84M	7.62M	118.37M	86.04M	51.18M
Total Liabilities	2.95M	12.87M	20.88M	57.39M	50.53M
Total Current Liabilities	1.42M	7.34M	11.25M	21.95M	14.94M
Total Non-Current Liabilities	3.06M	9.41M	14.24M	35.86M	36.18M
Total Equity	5.84M	7.62M	118.37M	86.04M	51.18M
Common Equity	0	0	3.65M	3.72M	3.72M
Retained Earnings	-13.7M	-33.39M	-76.16M	-108.07M	-148.07M